These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 27744564)

  • 1. Trends on polymer- and lipid-based nanostructures for parenteral drug delivery to tumors.
    Ajorlou E; Khosroushahi AY
    Cancer Chemother Pharmacol; 2017 Feb; 79(2):251-265. PubMed ID: 27744564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in polymeric micelles for anti-cancer drug delivery.
    Biswas S; Kumari P; Lakhani PM; Ghosh B
    Eur J Pharm Sci; 2016 Feb; 83():184-202. PubMed ID: 26747018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active targeting strategies for anticancer drug nanocarriers.
    Basile L; Pignatello R; Passirani C
    Curr Drug Deliv; 2012 May; 9(3):255-68. PubMed ID: 22452402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organic nanocarriers for cancer drug delivery.
    López-Dávila V; Seifalian AM; Loizidou M
    Curr Opin Pharmacol; 2012 Aug; 12(4):414-9. PubMed ID: 22465543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in co-delivery systems based on polymeric nanoparticle for cancer treatment.
    Afsharzadeh M; Hashemi M; Mokhtarzadeh A; Abnous K; Ramezani M
    Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1095-1110. PubMed ID: 28954547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanomedicines based drug delivery systems for anti-cancer targeting and treatment.
    Jain V; Jain S; Mahajan SC
    Curr Drug Deliv; 2015; 12(2):177-91. PubMed ID: 25146439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoparticles for tumor targeted therapies and their pharmacokinetics.
    Wang J; Sui M; Fan W
    Curr Drug Metab; 2010 Feb; 11(2):129-41. PubMed ID: 20359289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted nanoparticulate drug-delivery systems for treatment of solid tumors: a review.
    Bhattacharjee H; Balabathula P; Wood GC
    Ther Deliv; 2010 Nov; 1(5):713-34. PubMed ID: 22833959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Advances in the study of tumor pH-responsive polymeric micelles for cancer drug targeting delivery].
    Xu JX; Tang JB; Zhao LH; Shen YQ
    Yao Xue Xue Bao; 2009 Dec; 44(12):1328-35. PubMed ID: 21351464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting.
    Huynh NT; Roger E; Lautram N; Benoît JP; Passirani C
    Nanomedicine (Lond); 2010 Nov; 5(9):1415-33. PubMed ID: 21128723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymer-Lipid Hybrid Nanoparticles: A Next-Generation Nanocarrier for Targeted Treatment of Solid Tumors.
    Rizwanullah M; Alam M; Harshita ; Mir SR; Rizvi MMA; Amin S
    Curr Pharm Des; 2020; 26(11):1206-1215. PubMed ID: 31951163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Passive and active targeting in cancer therapy by liposomes and lipid nanoparticles.
    Alavi M; Hamidi M
    Drug Metab Pers Ther; 2019 Feb; 34(1):. PubMed ID: 30707682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanotherapeutics in oral and parenteral drug delivery: Key learnings and future outlooks as we think small.
    Tyagi P; Subramony JA
    J Control Release; 2018 Feb; 272():159-168. PubMed ID: 29355619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?
    Qu J; Zhang L; Chen Z; Mao G; Gao Z; Lai X; Zhu X; Zhu J
    Drug Deliv; 2016 Nov; 23(9):3408-3416. PubMed ID: 27181462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced permeability and retention of macromolecular drugs in solid tumors: a royal gate for targeted anticancer nanomedicines.
    Greish K
    J Drug Target; 2007; 15(7-8):457-64. PubMed ID: 17671892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of polydopamine in tumor targeted drug delivery system and its drug release behavior.
    Wang Z; Duan Y; Duan Y
    J Control Release; 2018 Nov; 290():56-74. PubMed ID: 30312718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in lipid nanodispersions for parenteral drug delivery and targeting.
    Constantinides PP; Chaubal MV; Shorr R
    Adv Drug Deliv Rev; 2008 Mar; 60(6):757-67. PubMed ID: 18096269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticle technologies for cancer therapy.
    Alexis F; Pridgen EM; Langer R; Farokhzad OC
    Handb Exp Pharmacol; 2010; (197):55-86. PubMed ID: 20217526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Computational/Experimental Assessment of Antitumor Activity of Polymer Nanoassemblies for pH-Controlled Drug Delivery to Primary and Metastatic Tumors.
    Curtis LT; Rychahou P; Bae Y; Frieboes HB
    Pharm Res; 2016 Oct; 33(10):2552-64. PubMed ID: 27356524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.